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Aim: Abnormal daily sleep duration and quality have been linked to hypertension, diabetes, stroke, 
and overall cardiovascular disease (CVD) morbidity& mortality. However, the relationship between 
daily sleep duration and quality with subclinical measures of CVD remain less well studied. This sys-
tematic review evaluated how daily sleep duration and quality affect burden of subclinical CVD in 
subjects free of symptomatic CVD.
Methods: Literature search was done via MEDLINE, EMBASE, Web of Science until June 2016 and 
32 studies met the inclusion criteria. Sleep duration and quality were measured either via subjective 
methods, as self-reported questionnaires or Pittsburg Sleep Quality Index (PSQI) or via objective 
methods, as actigraphy or polysomnography or by both. Among subclinical CVD measures, coronary 
artery calcium (CAC) was measured by electron beam computed tomography, Carotid intima-media 
thickness (CIMT) measured by high-resolution B-mode ultrasound on carotid arteries, endothelial/
microvascular function measured by flow mediated dilation (FMD) or peripheral arterial tone (PAT) 
or iontophoresis or nailfold capillaroscopy, and arterial stiffness measured by pulse wave velocity 
(PWV) or ankle brachial index (ABI).
Results: Subjective short sleep duration was associated with CAC and CIMT, but variably associated 
with endothelial dysfunction (ED) and arterial stiffness; however, subjective long sleep duration was 
associated with CAC, CIMT and arterial stiffness, but variably associated with ED. Objective short 
sleep duration was positively associated with CIMT and variably with CAC but not associated with 
ED. Objective long sleep duration was variably associated with CAC and CIMT but not associated 
with ED. Poor subjective sleep quality was significantly associated with ED and arterial stiffness but 
variably associated with CAC and CIMT. Poor objective sleep quality was significantly associated 
with CIMT, and ED but variably associated with CAC.
Conclusions: Overall, our review provided mixed results, which is generally in line with published 
literature, with most of the studies showing a significant relationship with subclinical CVD, but only 
some studies failed to demonstrate such an association. Although such mechanistic relationship 
needs further evaluation in order to determine appropriate screening strategies in vulnerable popula-
tions, this review strongly suggested the existence of a relationship between abnormal sleep duration 
and quality with increased subclinical CVD burden.
Key words: Sleep duration, Sleep quality, Subclinical cardiovascular disease, Coronary Artery Calcium 
(CAC), Carotid intima media thickness (CIMT), Endothelial function, Flow Mediated 
Dilation (FMD), Arterial stiffness, Pulse Wave Velocity (PWV)
Copyright©2017 Japan Atherosclerosis Society
This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.
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CVD markers need to be studied in more detail. As 
early recognition of subclinical CVD in people with 
sleep disturbances may impact risk stratification and 
early treatment of subclinical CVD before the devel-
opment of clinical CVD events.
The purpose of this systematic review is to evalu-
ate the following: First the relationship between self-
reported or/and objectively assessed sleep duration 
with markers of subclinical CVD. Second, the relation-
ship between self-reported or/and objectively assessed 
sleep quality with markers of subclinical CVD. Third, 
the effect of acute and chronic sleep deprivation on 
subclinical CVD risks. Such association of sleep 
parameters with subclinical CVD would provide the 
importance of regular sleep habits and would provide 
evidence to the stakeholders to consider sleep distur-
bances as important risk factors for determination of 
future risk of CVD events. This systematic review may 
also highlight the role of noninvasive cardiovascular 
diagnostic procedures in those with sleep disturbances.
Methods
An electronic systematic literature search was 
performed using the EMBASE (via EMTREE) and 
Medline database (National Library of Medicine, 
Bethesda, MD via PubMed) for relevant literature up 
to March 2016 (Fig.1). We used both MeSH and 
Emtree terms and relevant free text terms. The follow-
ing search terms (synonyms and combinations) were 
used: “sleep duration” and/or “sleep quality”. These 
terms were combined with “sub clinical cardiovascular 
disease risks”, “coronary artery calcium (CAC)”, 
“carotid intima-media thickness (CIMT)”, “endothe-
lial function and/or microvascular function via flow 
mediated dilation (FMD) and/or peripheral arterial 
tone (PAT) and/or iontophoresis and/or nailfold cap-
illaroscopy”, and “arterial stiffness via pulse wave 
velocity (PWV)”, and/or ankle brachial index (ABI)”.
The search results were manually scanned for rel-
evant articles by three independent reviewers. Refer-
ences of obtained articles were used for additional 
articles. The search was limited to original research 
studies on human subjects published in English lan-
guage. We included (1) original research articles, AND 
(2) studies that reported subjective and/or objective 
sleep duration AND/OR (3) studies that reported 
subjective and/or objective sleep quality, AND (4) 
studies that reported PSQI good vs PSQI bad sleep 
quality and/or insomnia vs. non-insomnia and/or shift 
vs. non-shift work and/or arousal index and/or sleep 
efficiency (%) and/or sleep Fragmentation index and/
or REM/Non-REM sleep, AND (5) studies that 
reported an assessment of Non-Invasive Subclinical 
Introduction
A good hygienic sleep is an essential part of 
everyday life. It is estimated that humans spend one 
third of their lifetime sleeping. An estimated 50–70 
million Americans suffer from sleep disorders, yet only 
20% report it to their physicians1). Poor sleep may be 
a risk factor for cardiovascular disease (CVD) and has 
serious biological consequences2). A growing body of 
literature suggests a relationship of sleep parameters 
(sleep duration and sleep quality) with CVD, stroke, 
and all-cause morbidity & mortality3). A recent review 
of 23 studies determined that both short and long 
sleep is related to increased risk for all-cause mortality 
among both men and women, compared to individu-
als who report a medium amount of daily sleep (7 –8 
hours)4), however, some studies have shown that the 
sleep disturbances may be associated with CVD mor-
tality with weaker evidence for women5). Additionally, 
acute and chronic sleep deprivation can lead to weight 
gain, impaired glucose tolerance, activate pro-inflam-
matory pathways, increased sympathetic activity and 
higher cortisol levels in healthy subjects6).
The epidemiological data suggests strong associa-
tion of subjectively and/or objectively measured sleep 
parameters with classical CVD risk factors like hyper-
tension, insulin resistance, hypercholesterolemia, type 
2 diabetes and increase in the inflammatory markers 
leading to subclinical and clinical CVD7-10). The tradi-
tional risk stratification has relied mainly on scoring 
systems such as the Framingham risk score to deter-
mine the CVD risks11). However, newer non-invasive 
techniques that assess coronary artery calcium (CAC), 
carotid intima-media thickness (CIMT), flow-medi-
ated dilation (FMD), Ankle Brachial Index (ABI) and 
pulse wave velocity (PWV) provide refined assessment 
of early atherosclerosis process, endothelial dysfunc-
tion and arterial stiffness potentially leading to clinical 
CVD events. The extent of CAC and CIMT corre-
lates with plaque burden and atherosclerosis, decreased 
FMD correlates with endothelial dysfunction, decreased 
ABI but increased PWV measure increasing arterial 
stiffness12-15). There are some studies that show rela-
tionship of these non-invasive subclinical CVD mark-
ers with disturbed sleep parameters16, 17) and signify 
the importance of regular sleep habits but such rela-
tionships between the sleep parameters and subclinical 
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(angina, myocardial infarction and heart failure) and 
cerebrovascular diseases (stroke) (4) the studies that 
that have discussed the effect of mental disorders on 
sleep duration and sleep quality (5) the studies in 
which participants used any kind of sleeping pills. 
Thirty-two studies met the inclusion criteria for final 
review from an initial search result of 186 articles 
(Fig.1 for search algorithm). The authors stated that 
no financial support was given and that no off-label or 
investigational use of a drug or device was performed 
as part of this research.
Sleep duration typically defines as “the total 
amount of sleep obtained, either during the nocturnal 
sleep episode or across the 24-hour period”19). In the 
studies discussed in this review, the sleep duration was 
CVD assessment tools as Coronary Artery Calcium 
(CAC) and/or Carotid Intima Media Thickness 
(CIMT) and/or Endothelia function and/or Arterial 
stiffness. The aim of this review was to summarize the 
evidence of regular daily sleep duration and sleep qual-
ity with subclinical CVD, so we excluded any study 
that discussed the association of sleep disorders and 
clinical cardiovascular and cerebrovascular diseases. 
Many research studies have shown that sleep disorders 
like obstructive sleep apnea has been previously shown 
to be strongly associated with subclinical CVD18). In 
our exclusion criteria, we excluded (1) the letters, edi-
torials (2) the studies on subjects with sleep disorders 
[obstructive sleep apnea (OSA), parasomnias, and nar-
colepsy] (3) the studies that discussed clinical CVDs 
Fig.1. Literature Search Strategy
CVD: Cardiovascular disease, CAC: Coronary artery calcium, CIMT: Carotid intima-
media thickness.
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2008




CAC (Agatston score)- 
electron beam CT
Matthews et al. 
(31), 2011





CAC (Agatston score)- 
electron beam CT
Matthews et al. 
(32), 2013




CAC (Agatston score)- 
electron beam CT
Lutsey et al (34), 
2015
United States Cross-sectional 1465 (68; 54%) NR
Actigraphy and 
PSG
CAC (Agatston score)- 
electron beam CT








CAC (Agatston score)- 
electron beam CT
Wolff et al. (35), 
2008
Germany Cross-sectional 2383 (45–81; 51%) Self-Report NR
CIMT (mm)- B-mode 
ultrasound
Abe et al. (36), 
2011




CIMT (mm)- B-mode 
ultrasound
Nakazaki et al. 
(38), 2012




CIMT (mm)- B-mode 
ultrasound
Sands et al. (39), 
2012
United States Cohort 617 (37–52; 58%) NR Actigraphy
CIMT (mm)- B-mode 
ultrasound
Nagai et al. (2), 
2013




CIMT (mm)- B-mode 
ultrasound
Ma et al. (37), 
2013




CIMT (mm)- B-mode 
ultrasound
Ramos-
Sepulveda et al. 
(41), 2010




CIMT (mm)- B-mode 
ultrasound
Schwartz et al. 
(40) 2102
United States Cross sectional 126 (55; 89%) NR Actigraphy
CIMT (mm)- B-mode 
ultrasound
Behl et al. (43), 
2014




Cooper et al. 
(42), 2014




Calvin et al. (44), 
2014
United States Cross-sectional 16 (18 to 40; 37.5%) NR PSG EF- FMD
Takase et al, 
2004 (45)
Japan Cross-sectional 30 (21.7±1.1; 0%) Self-Report NR EF-FMD








Schmidt et al, 
2013 (47)
Germany Cross-sectional 75 (20–54; 61.3%) NR Actigraphy EF-FMD
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whereby the objective sleep quality is defined not only 
by sufficient duration, high efficiency, and low frag-
mentation, but also by proper staging of sleep (i.e., 
cycling through non-REM (stages 1–4) and REM)23). 
In this review, the sleep quality was measured via sub-
jective methods, including Pittsburg Sleep Quality 
Index (PSQI) and/or self-reporting of insomnia vs 
non-insomnia, shift vs non-shift work, arousal index, 
or via objective measures, which include actigraphy 
and/or polysomnography or by both subjective and 
objective methods20, 21). The Pittsburgh Sleep Quality 
Index (PSQI) is an effective tool used to measure the 
quality and patterns of sleep in adults. It differentiates 
“poor” from “good” sleep quality by measuring seven 
measured either via subjective methods, including self-
reported questionnaires and/or Pittsburg Sleep Qual-
ity Index (PSQI) or via objective measures, which 
include actigraphy and/or polysomnography or by 
both subjective and objective methods20, 21). The sub-
jective sleep quality is defined as “one’s perception that 
they fall asleep easily, get sufficient duration so as to 
wake up feeling rested, and can make it through their 
day without experiencing excessive daytime sleepi-
ness”22). Using actigraphy to objectively measure sleep 
quality, the objective sleep quality is defined by suffi-
cient duration (＞7 hrs), high efficiency (＞85%), and 
low fragmentation (＜25)23). Using polysomnography 
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2012






Austria Cross-sectional 48 (43±5; 0%)
Self-report 
questionnaire
NR EF- PAT index
Dettoni et al. 
(50), 2012
Brazil Cross-sectional 13 (31±2; 0%) NR Actigraphy
EF (dorsal hand vein 
technique)
Sauvet et al. (51), 
2009
France Cross-sectional 12 (29±3; 0%) Self-report NR
EF (Iontophoresis of 
Acetylcholine & Na- 
nitroprusside)
Bonsen et al. 
(52), 2015






Weil et al. (53), 
2010
United States Cross-sectional 80 (56.6±1.2; 39%) Self-Report NR
EF- Endothelin (ET)-1 
levels
Weil et al. (54) , 
2011
United States Cross-sectional 37 (58±1.5; 41%) Self-Report NR
EF- Endothelial 
progenitor cells (EPCs) 
functions
Yoshioka et al. 
(55), 2011
Japan Cross-sectional 4268 (48±7; 20%) Self-Report NR AS-baPWV
Sunbul et al. 
(56), 2014




Tsai et al. (57), 
2014
Taiwan Cross-sectional
3, 508 (age 20–87, 
40%)
Self-Report NR AS-baPWV








Yamaki et al. 
2015,




Abbreviation: NR: Not – reported; SWEL: Sleep Wake Experience List questionnaire
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the sleep fragmentation index, the more sleep is dis-
rupted25).
Among subclinical cardiovascular disease (CVD) 
measures, the coronary artery calcium (CAC) was 
measured by either electron beam computed tomogra-
phy (EBCT) or multidetector computed tomographic 
(MDCT) scanner. Increased calcium deposition in 
coronary arteries is related to the presence of athero-
sleep components that include subjective sleep quality, 
sleep latency, sleep duration, habitual sleep efficiency, 
sleep disturbances, use of sleeping medications, and 
daytime dysfunction over the last month24). Sleep 
fragmentation is defined as “an index of restlessness 
during the sleep period expressed as a percentage”. It 
is calculated as movement index, a fragmentation 
index, and total sleep fragmentation Index. The higher 










Subjective/ Self-reported Sleep Duration





Logistic regression of incident CAC [OR (95% CI):
Self-reported sleep per hour (Adja): 0.87 (0.67–1.13), 
p=0.30





Self-reported Sleep duration (hr) among CAC groups:
CAC=0: 6.41 (1.25)
CAC=1–99: 6.51 (1.18)
CAC=100＋: 6.48 (1.19), p=0.88





No significant association between longer self-reported 









Sleep duration vs. CAC Score (Adjb): OR (95% CI)
≤5 h: 1.50 (1.17–1.93); p: 0.002
6 h: 1.34 (1.10–1.63); p: 0.002
7 h: 1.00 (Reference)
8 h: 1.37 (0.99–1.89); p: ≥0.05
≥9 h: 1.72 (0.90–3.28); p: 0.002
The association 
between sleep dura-
tion and CAC is 
“U-shaped”.
Objective Sleep Duration
King et al. (33), 
2008
Actigraphy CAC
Logistic regression of incident CAC [OR (95% CI): 
Actigraph measured sleep per hour (Adjc): 0.66 (0.48–
0.92), p=0.01





Objective sleep duration (hr) among CAC groups:
Actigraphy: PSG
CAC=0 5.78 (0.98) 6.11 (0.91)
CAC=1-99 5.80 (0.82) 6.16 (1.00)
CAC=100＋ 5.92 (0.79) 5.90 (1.04)
P value p=0.64 p=0.89
Sleep duration both 
by Actigraphy and 
PSG was not signif-
icant





Sleep duration (h) vs CAC ≥400: PR (95% CI): 
≤6.65h: 0.75 (0.55–1.03), p=0.08
6.65–7.4 h: Ref
≥7.40h: 0.84 (0.56–1.26), p=0.40
Fully adjusted 
model is not related 
to high prevalence 
of CAC.
aAdjusted for race, sex, age, smoking, education, and apnea risk
bAdjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body 
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.
cAdjusted for race, sex, age, smoking, education, apnea risk, BMI, HDL, LDL, BP, DM
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chial, radial or femoral arteries. The decrease in the 
flow mediated dilatation is closely related to endothe-
lial cells dysfunction that leads to increased risk of ves-
sels wall injury causing both the early and late mecha-
nisms of atherosclerosis that include increased leuko-
cyte adherence, platelet activation, and vascular smooth 
muscle proliferation and decreased production of nitric 
oxide14). The PAT is calculated by EndoPAT device 
(Itamar Medical, Israel) that involves measuring the 
pulse amplitude in the fingertip at rest and following 
the induction of reactive hyperemia. The EndoPAT 
device consists of a fingertip plethysmograph capable 
sclerotic process and increased plaque burden12). The 
carotid intima-media thickness (CIMT) was measured 
using high-resolution B-mode ultrasonography on 
carotid arteries and increased intima media thickness 
in carotid artery is related to carotid atherosclerosis 
and future increased risk of CVD13). The endothelial 
function and/or microvascular function was measured 
by flow mediated dilation (FMD) and/or peripheral 
arterial tone (PAT) and/or iontophoresis and/or nail-
fold capillaroscopy. The FMD is based on an ultra-
sound test that measures the changes in the arterial 
diameter based on their blood flow such as the bra-










Subjective/ Self-reported Sleep Quality





Logistic regression of incident CAC: (OR; 95%CI):
PSQI Score (per SD=2.9 points) (Adjd): 1.21 (0.88–
1.65), p=0.24
Epworth Score (per SD=4.0 points) (Adjd): 1.26 (0.96, 
1.66), p=0.10





Self-reported sleep quality or efficiency did not differ by 
CAC groups (p＞0.15)
Apnea/Hypopnea 
Index was associated 
with increased CAC 
scores (p=0.04).





Poor sleep quality was not associated with odds of being 
in a higher coronary artery calcification (CAC) group.
Women only





CAC Score by sleep quality: Adjb OR (95% CI): Good 
vs. Poor sleep quality:
Men: 1.00 (Reference) vs. 1.10 (0.86–1.42)
Women: 1.00 (Reference) vs. 2.46 (1.30–4.65); p≤0.05
Poor subjective sleep 
quality was associated 
with CAC in women 
only in both crude and 
adjusted model.
Objective Sleep Quality
King et al. (33), 
2008
Actigraphy CAC
Logistic regression of incident CAC: (OR; 95%CI)
Fragmentation Index (per SD=7.7 points)d: 1.07 (0.80, 
1.42), p=0.66





Sleep quality or efficiency measures did not differ by 
CAC groups (CAC=0 vs CAC ＞0); p＞0.05





Sleep quality vs CAC ≥400: PR (95% CI)
Arousal index— 1.14 (1.02 to 1.27); p=0.02
Arousal index—REM: 1.15 (1.02 to 1.29); p=0.02
Arousal index—NREM: 1.14 (1.02 to 1.28); p=0.03
Average sleep efficiency%—1.00 (0.89 to 1.13); p=0.97
Average sleep WASO—1.03 (0.91 to 1.17); p=0.62
dAdjusted for race, sex, age, smoking, education, and apnea risk.
bAdjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body 
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.
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third finger is used to determine the endothelial func-
tion. The measurements are conducted after at least 
30 min of rest and with a minimum hand temperature 
of 28℃. The microvascular measurements include the 
duplicate measurements of capillary density at the 
base of the interphalanx at rest and after 4 min of arte-
rial occlusion28). The arterial stiffness was measured 
via pulse wave velocity (PWV), and/or ankle brachial 
index (ABI). The PWV is the time the arterial pres-
sure wave takes to travel a distance between two arte-
rial sites and is measured distance (cm)/time (seconds). 
Higher value of PWV is directly correlated to the arte-
rial stiffness and when measured over the aorta, it rep-
resents an independent risk factor for increased cardio-
vascular disease15). There are different methods to 
measure the PWV that include brachial artery PWV 
(baPWV), carotid-femoral PWV (cfPWV), heart-fem-
oral PWV (hfPWV) and femoral-ankle PWV 
of sensing volume changes in the digit with each arte-
rial pulsation. The volume changes in the fingertip are 
documented digitally as pulse amplitude that can be 
tracked over time. The expected response is a post 
occlusion increase of the PAT signal amplitude and 
the PAT score is provided automatically by the sys-
tem’s software and is basically the ratio between the 
post- to pre-occlusion average signal size, corrected for 
systemic changes and baseline level26). Iontophoresis 
of acetylcholine (ACh) and sodium nitroprusside 
(SNP) is a tool used to determine microvascular endo-
thelial function. Two laser-Doppler probes specifically 
designed with an embedded sponge for skin iontopho-
resis of agonists are fixed 5 cm apart to the skin with 
an adhesive patch to measure the endothelium-depen-
dent and endothelium-independent vasodilatation to 
determine the endothelial function27). The nailfold 
capillary video microscopy of the dorsal skin of the 
















Mean difference (mm) in CIMT across hours of sleep: Adje
5h: 0.038 (0.002, 0.074); p＜0.0
6h: 0.007 (－0.012, 0.027); ns)
7h: 0.001 (－0.015, 0.018); ns)
8h: ref group
9h: 0.022 (0.000, 0.045); ns
10h: 0.043 (0.015, 0.070); p＜0.01
＞11h: 0.065 (0.017, 0.113); p＜0.01
The association of sleep 
duration with mean 
CIMT was J-shaped. The 
sleep duration group of 
7hrs exhibited lowest 
CIMT, SBP and HbA1c.





Odds ratio for presence of IMT ≥1.2 mm: Adj f
≤5h: 1.059 (0.764–1.467), p=≥0.05
6h: ref group
≥7h: 1.263 (1.031–1.546), p=0.024
The use of hypnotics like 
benzodiazepines dimin-
ished the association 
between sleep duration 
and increased CIMT.





Mean CIMT (mm): ＜5h sleep vs. ＞7h sleep: (1.3±0.5 
vs. 0.9±0.3); p=0.009
Association of sleep duration by PSQI with CIMTg: 
β=0.22, p=0.05
Elderly population.





CIMT (mm) among sleep groups:
＜6 hr: 1.03±0.29
≤6–9 hr: 1.01±0.29
≥9 hr: 1.09±0.35, (p=0.26)
Elderly population.















Thirty-two studies met the final selection criteria 
and discussed the relationship of subjective (self-report) 
and objective (actigraphy and/or polysomnography) 
sleep duration as well as subjective and objective sleep 
quality with non-invasive markers of subclinical CVD. 
Sleep duration and sleep quality are two distinct 
parameters of sleep, and these are discussed separately 
along with each non-invasive marker of subclinical 
CVD in respective tables. Five studies evaluated asso-
ciation of sleep parameters with coronary artery cal-
cium (CAC)17, 31-34), eight evaluated association with 
carotid intima-media thickness (CIMT)2, 35-41), thir-
teen evaluated association with endothelial func-
(faPWV) and these reflect properties of central, 
peripheral or mixed properties of both central and 
peripheral arterial stiffness. All studies used in this 
review discussed the relationship of sleep parameters 
with baPWV which is considered as an important 
parameter of both central and peripheral arterial stiff-
ness29). ABI is a measure reflective of systemic athero-
sclerosis and predict the stiffness in the vessels. The 
ABI is the ratio of the systolic blood pressure at the 
ankle to the average systolic blood pressure at the right 
arm. The lower the value of ABI below 1.0 correlates 












Nakazaki et al. 
(38), 2012
Actigraphy CIMT
Association of total sleep time by Actigraphy with 
CIMTg: β=－0.32, p=0.005
Sleep efficiency (%): Insomnia group vs. non-insomnia 
group (78.6±11.3 vs. 89.3±7.1); p=＜0.0001
Elderly population.
Sands et al. 
(39), 2012
Actigraphy CIMT
Linear regression for sleep duration (h) on CIMT (mm) 
Adjh: OR (95% CI)
Male: －0.026 (－0.047, －0.005); p=0.02
Female: －0.001 (－0.020, 0.022); p=0.91
Model significant in men 
only.
Ma et al. (37), 
2013
Actigraphy CIMT
Actigraphy measured sleep duration and mean CIMT 





8.0–10.7: 0.625±0.027 (p for all=0.692)
Police officers. .
Schwartz et al. 
(40) 2102
Actigraphy CIMT
Sleep duration (h) vs. CIMT (mm): β (95% CI) j
Nighttime sleep duration: －0.01 (－0.03, 0.01); p≥0.05
Daytime sleep duration: －0.04 (－0.07, －0.01); p≤0.05
Study was done on elderly 
Alzheimer Caregivers
eAdjusted for lifestyle variables include smoking status (number of cigarettes per day), alcohol consumption, physical activity, and shift work; 
socioeconomic factors include monthly family income, marital status, primary education, vocational status; and biological risk factors include BMI, 
lipid profile (total cholesterol/HDL cholesterol ratio), diabetes, previous myocardial infarction and hypertension.
fAdjusted for age, sex, LDL-cholesterol, HDL-cholesterol, triglyceride, fasting plasma glucose, HbA1c, fasting insulin, BMI, alcohol intake (never, 
monthly, weekly, daily), and current smoking
gAdjusted for age, gender, BMI, SBP, DBP, PSQI, AHI, lowest SpO2, sleep efficiency, total sleep time, hypertension, hyperlipidemia, diabetes, sleep 
apnea syndrome and insomnia.
hAdjusted for age, race/ethnicity, smoking, education, depression, BMI, systolic blood pressure, high- density lipoprotein cholesterol, low- density 
lipoprotein cholesterol, and diabetes
iAdjusted for age, gender, race/ethnicity, abdominal height, systolic blood pressure, anti-hypertensivemedications, glucose, low-density lipoprotein, 
high-density lipoprotein, lipid lowering medications, sleep quality (Pittsburgh Sleep Quality Index global score after removing sleep duration compo-
nent), perceived stress score, depressive symptoms score, physical activity index, smoking status, shiftwork, and having a second job.
jAdjusted for age and gender, education, BMI, physical activity, smoking, hypertension, dyslipidemia, diabetes, history of CVD, Role Overload and 
depression (CESD-10) scores
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robust with only one study among the total of three 
showed that poor sleep quality is associated with 
increased CAC among women only. Objective sleep 
quality only in the form of arousal index was directly 
associated with increased CAC as, higher the arousal 
index, higher the risk of being in a CAC group of 
CAC ≥400 Agatston units (Table 2b)
Association of Subjective and Objective Sleep 
Parameters with Carotid Intima Media Thickness 
(CIMT)
Table 3a showed that subjective and objective 
sleep duration were associated with CIMT with stron-
ger evidence present for shorter sleep duration with 
increased CIMT as compared with reference sleep 
hours (6–8 hours). The population used in these 
studies was heterogeneous with mostly elderly and 
police officers. Among all studies assessing the CIMT, 
the sleep duration group of average 7 hours exhibited 
lowest systolic blood pressure and Hemoglobin A1c.
Table 3b showed that most of the studies dis-
cussed the relationship of subjective sleep duration 
with CIMT. Only one study discussed association of 
tion42-54), and six studies assessed relationship with 
arterial stiffness17, 55-58). Kim et al. 2015 studied both 
the subjective sleep duration and subjective sleep qual-
ity with both CAC as well as PWV in same paper so 
the results of CAC and PWV outcomes were stated 
separately in the relevant tables17). Table 1 shows the 
baseline characteristics of all the studies used in this 
review.
Association of Subjective and Objective Sleep 
Parameters with Coronary Artery Calcium (CAC)
Table 2a shows the association of subjective and 
objective sleep duration with CAC. Kim et al. showed 
that association of subjective sleep duration with CAC 
is “U” shaped with stronger association of short sub-
jective sleep duration with increased CAC. King et al. 
showed that objective longer sleep duration is better 
predictor of CAC as compared to objective shorter 
sleep duration with 0.66 times increase in CAC with 
each hour increase in sleep duration. All other studies 
did not show any significant association of sleep dura-
tion with CAC.
The association of sleep quality with CAC is less 

























Association of sleep quality by PSQI with CIMTk: β=0.22, 
p=0.05
Mean IMT (mm): Insomnia group vs. non-insomnia group
(1.3±0.5 vs. 1.1±0.4); p=0.03
Elderly population 
only.





Mean IMT (mm): Insomnia group vs. non-insomnia group
(1.16±0.37 vs. 1.04±0.30); p＜0.01
Elderly patients.





PSQI sleep quality score& CIMT (mm):
Pearson correlation coefficient (r)=－0.0762; p=0.235
Police officers.
Ramos-Sepulveda 




Association of insomnia with CIMT (mm)Adjl: OR (95% CI)




Schwartz et al. 
(40) 2102
Actigraphy CIMT
Sleep quality vs. CIMT (mm): β (95% CI) j
Nighttime WASO: 0.04 (0.001, 0.08), p≤0.05
Study was done on 
elderly Alzheimer 
Caregivers
kAdjusted for age, gender, BMI, SBP, DBP, PSQI, AHI, lowest SpO2, sleep efficiency, total sleep time, hypertension, hyperlipidemia, diabetes, sleep 
apnea syndrome and insomnia.
lAdjusted for age sex, race LDL, HDL BMI hypertension, diabetes, current smoker and any cardiac disease.




Association of Subjective and Objective Sleep 
Parameters with Arterial Stiffness
Table 5a discussed the association of subjective 
sleep duration with arterial stiffness. All studies 
showed that subjective long sleep duration was associ-
ated with increased arterial stiffness; however, only 
one study showed a relationship between subjective 
short sleep duration and arterial stiffness and other 
studies failed to demonstrate such association.
In Table 5b, all studies that discussed the subjec-
tive association of sleep quality with arterial stiffness, 
showed a strong positive association of bad sleep qual-
ity with arterial stiffness in terms of increased brachial 
artery pulse wave velocity (baPWV) and decreased 
ankle brachial index (ABI). There was no study in this 
review that reported the association of objective sleep 
quality with arterial stiffness.
Discussion
This systematic review investigated the associa-
tion of subjectively and/or objectively measured sleep 
duration as well as sleep quality with non-invasive 
markers of sub-clinical cardiovascular disease (CVD). 
According to this review, subjective short sleep dura-
tion was associated with CAC and CIMT, but variably 
the objective sleep quality with CIMT and it was sig-
nificant (p≤0.05). Among these studies insomnia was 
strongly associated with CIMT as compared to non-
insomnia. PSQI as a parameter of sleep quality was 
discussed only in two studies and was significant only 
in one study (β=0.22, p=0.05).
Association of Subjective and Objective Sleep 
Parameters with Endothelial Functions
Table 4a discussed the subjective and objective 
sleep duration with endothelial functions. Among 
total of five studies, only one study discussed the 
objective sleep duration and endothelial functions and 
it was not significant. Among the other four studies, 
only two studies showed the significant association of 
subjective sleep duration with endothelial dysfunc-
tions.
Table 4b discussed the subjective and objective 
sleep quality with endothelial functions. Most of the 
studies showed a significant association of low sleep 
quality with reduced endothelial functions. The low 
sleep quality was expressed variably in these studies by 
PSQI quality scores, acute sleep deprivation, difficul-
ties initiating sleep or maintaining sleep, REM sleep, 
REM latency, noise level during sleep, chronic stress 
vs no stress, shift vs. non-shift workers.
















Total PSQI score was unrelated to brachial artery 
FMD; p=≥0.05






Sleep duration & endothelial function: regression 
coefficient 95% CI
Men: β=－0.79, 95% CI (－7.20 to 5.63), p=0.81
Women: β=－11.17, 95% CI (－21.80 to －0.55); 
p=0.04
Significant only in 
women






Sleep duration and endothelial function as ET-1-
mediated vasoconstrictor tone: (Correlation) r =  
－0.32; p＜0.01
Increased ET-1 vasocon-
strictor activity positively 
correlated with CVD risks.







There were no significant correlations between 
sleep duration and any endothelial progenitor 
cells (EPCs) measure.
Circulating endothelial 
progenitor cells (EPCs) are 
vital to endogenous vascu-
lar repair processes and 
cardiovascular health.
Objective Sleep Duration
Cooper et al. 
(42), 2014
Polysomnography EF (FMD)
Total sleep time (TST) was not associated with 
FMD: (Correlation) r =0.03; p=≥0.05
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ing that both short and long sleep durations were 
associated with a greater relative risk of coronary heart 
disease and stroke60). Sleep quality as assessed by 
insomnia and sleep deprivation have also been linked 
with adverse CVD outcomes. Westerlund et al. 
revealed that insomnia itself was not related to CVD 
risk, but when considered together with short sleep 
duration, there was a higher risk of overall cardiovas-
cular events3). The exact mechanism by which com-
promised sleep quality lead to CVD is not clear, but 
possible explanations include changes in hormones 
and inflammatory markers, lipid levels, glucose toler-
ance/metabolism, sympathetic nervous system and 
subclinical atherosclerosis61). Cappuccio et al. per-
formed another systematic review and meta-analysis in 
2010 of 10 cohort studies showing that sleep ≤5–6 h 
and ＞8–9h were associated with higher relative risk 
of developing Type 2 DM62). Gangwisch et al. showed 
associated with endothelial dysfunction (ED) and 
arterial stiffness, however subjective long sleep dura-
tion was associated with CAC, CIMT and arterial 
stiffness, but variably associated with ED. Objective 
short sleep duration was positively associated with 
CIMT, variably with CAC but not associated with 
ED. Objective long sleep duration was variably associ-
ated with CAC and CIMT but not associated with 
ED. Poor subjective sleep quality was significantly 
associated with ED & arterial stiffness but variably 
associated with CAC& CIMT. Poor objective sleep 
quality was significantly associated with CIMT, and 
ED but variably associated with CAC (Table 6)
There is a growing body of literature linking 
sleep duration with CVD outcomes. Sabanayagham et 
al. revealed a higher odds of myocardial infarction and 
stroke in subjects that slept ≤5 h and ≥9h59). In 2011, 
Cappuccio et al. performed a systematic review show-










Subjective/ Self-reported Sleep Quality






Low PSQI quality component was associated with 
lower FMD; p=0.038
Higher ESS scores were associated with lower 
FMD; p=0.026






Total PSQI Scores and FMD%: β=－0.22; 
p=0.024
% REM sleep and FMD%: β=0.25; p=0.022
REM latency and FMD%: β=－0.2; p=0.036
Takase et al, 
2004 (45)
Self-report EF (FMD)
FMD (%): Controls vs. Chronic stress: 
7.4±3.0 vs 3.7±2.3; p＜0.05
Only male sample





There were no significant effects of day, time, 
group, or interactions on%FMD among both 
shift and non-shift workers.
Only male sample






There was no evidence for an association of 
having difficulties initiating sleep or maintaining 
sleep with FMD in both genders.
Suessenbacher 




PAT index: shift vs non- shift workers:
1.73±0.4 vs 1.94±0.5; p=0.03
Only male sample




of Ach & Na- 
nitroprusside)
The endothelium-dependent and – independent 
cutaneous vascular conductance were significantly 
decreased after 29 h of TSD (P≤0.05).








Sleep quality& endothelial function: regression 
coefficient 95% CI
Men: β －3.81, 95% CI (－9.45, 1.83); p=0.18
Women: β 2.11, 95% CI (－3.14, 7.36); p=0.43
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cells66). According to a review by Elliott et al. sleep 
deprivation can cause death sooner than food depriva-
tion in both Drosophila and rats, further favoring 
importance of regular sleep habits67).
Our review provided mixed results in terms of 
subjective and/or objective short and/or long sleep 
duration and sleep quality with sub-clinical CVD, 
with a greater percentage of studies showing a rela-
tionship with sub-clinical CVD. However, only some 
studies in this review failed to demonstrate such an 
association31, 32, 37, 43) and one possible reason for such 
results could be due to the use of subjective/self-report 
versus objectively measured sleep parameters to assess 
the association with subclinical CVD causing biased 
results. Lauderdale et al. found a correlation between 
self-reported and objectively measured sleep duration 
of 0.45, which is generally considered as a moderate 
correlation. In current review, while one study reports 
a “J-shaped” association35), the other two study reports 
a “U- shaped” association17, 37) between sleep duration 
and sub-clinical CVD outcomes. Some studies report a 
positive association of sleep duration with sub-clinical 
CVD only with short sleep duration; some only with 
long sleep duration; some studies show a positive asso-
that ≤5 hours of sleep significantly increased the risk 
of hypertension63). Dettoni et al. showed that five 
nights of partial sleep deprivation can significantly 
cause a trigger in the sympathetic activity and venous 
endothelial dysfunction and this evidence is in align-
ment with the association between short sleep and 
increased cardiovascular risk in other epidemiological 
studies50).
Many animal studies have also found sleep depri-
vation causes an increase in endothelin levels. Endo-
thelin is a potent vasoconstrictor that has been impli-
cated in the pathogenesis of hypertension64). Meier-
Ewert et al. revealed that both total (88 hrs of no 
sleep) and short-term partial sleep (4.2 hrs of sleep) 
deprivation resulted in elevated high-sensitivity CRP 
concentrations, compared to those who slept 8.2 
hours65). Sauvet et al. demonstrated that total sleep 
deprivation in rats induces a reduction in endothelial-
dependent vasodilation independent of blood pressure 
and sympathetic activity64). Carreras et al. showed in 
mice that long-term sleep fragmentation lead to vascu-
lar endothelial dysfunction, mild increase in blood 
pressure, vascular elastic fiber disruption and disorga-
















% REM sleep and FMD%: β=0.25; p=0.022







FMD%: Acclimation phase vs. Experimental phase
Sleep restriction group: 8.6±4.6% vs 5.2±3.4%; 
p=0.01
Control group: 5.0±3.0% vs 6.73±2.9%; p=0.10
Group differences: －4.40%. 95% CI (－7.00,    
－1.81); p=0.003
Smaller sample






Noise60 dB: 9.5＋4.3%; p=0.052
A monotone dose-dependent effect of noise level 
on FMD was significant (p=0.020)
There was a priming 
effect of noise, i.e. the 
blunting in FMD was 
particularly evident when 
subjects were exposed 
first to 30 and then to 60 
noise events (p=0.006).
Dettoni et al. (50), 
2012
Wrist actigraphy
EF (dorsal hand 
vein technique)
Endothelial dependent venodilatation in sleep 
groups:
Control sleep (＞7h): 100±22%
Partial sleep deprivation (＜5 h): 41±20%); p＜
0.05
5 nights of partial sleep 
deprivation was sufficient 
to cause significant 
venous endothelial 
dysfunction.
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of subclinical CVD burden due to changes in the 
sleep parameters in specific age groups and gender.
Our systematic review findings need to be con-
sidered in light of the following limitations. The meta-
analysis for this review is not applicable because the 
studies included in our review are highly heteroge-
neous in population, outcome reporting and sleep 
duration and quality assessment groups, precluding a 
quantitative or meta-analytical synthesis of evidence. 
Some studies reported only subjective measures of 
sleep duration and sleep quality, some only objective 
measures, and some both. Not all studies used similar/
standardized subjective and objectives measures of 
sleep duration and quality. Some studies used simple 
questionnaire to measure sleep duration and quality, 
some used Pittsburgh Sleep Quality Index (PSQI), 
some used actigraphy and some used polysomnogra-
phy creating further heterogeneity in assessment of 
predictor variable. Furthermore, the reference/control 
sleep duration used in these studies was not a stan-
ciation with both short and long duration33, 38, 39, 57) 
but almost all studies favor the duration of the refer-
ence sleep (average 6 –8 hours of regular daily sleep). 
To our surprise, some studies have even shown long 
sleep hours is related to decrease in CAC33), decrease 
in CIMT38-40), decrease in PWV56) and one study by 
Yoshioka et al.55) even showed that sleep duration of 
≤6 hours was associated with a significant decrease in 
PWV and thus produced a great source of heterogene-
ity in the review. Although most of the studies in the 
current review demonstrate that sleep parameters are 
associated with early sub-clinical CVD, there is, as yet, 
no consensus on the biological pathways linking these 
processes. It is entirely possible, given the complexity 
of factors responsible for sleep habits that sleep distur-
bances may be an epiphenomenon of subclinical and 
clinical CVD rather than the proximate cause1). The 
population used in these studies is highly heteroge-
neous based on age and gender differences, and thus 
no consensus can be made about the particular nature 
















Association of sleep duration and mean baPWV: 
PRC (95%CI) Adjm: 
≤5h, 6h, 8 h, p=≥0.05
≥9hr: 44.69 (17.69-71.69); p＜0.01
In gender stratified analy-
ses, ≥9h sleep duration 
was associated with 
increased baPWV in males 
only (p＜0.01).





Relationship of sleep duration with arterial 
stiffness: Adjn
Males: Short Sleep: 0.98 (0.72–1.35); p=0.920
Long sleep: 1.75 (1.04–2.94); p=0.034
Females: Short Sleep: 0.86 (0.56–1.31); p=0.476
Long Sleep: 1.02 (0.48–2.15); p=0.963





Sleep duration (h) vs PWV (cm/s) (Adjb): OR 
(95% CI)
＜5h: 6.7 (0.75–12.6)
6h: 2.9 (－1.7 to 7.4)
7h: Reference (0.0)
8h: 10.5 (4.5–16.5)
9h: 9.6 (－0.7 to 19.8); p=0.019
The association between 
sleep duration and baPWV 
was U-shaped
Objective Sleep Duration
Not even a single study have described the association of objective sleep duration with Arterial Stiffness.
mAdjusted for age, sex, SBP, hypertension, HR, biological risk factors (BMI, TC, log TG, HDL-C, and FBS), lifestyle factors (education, exercise, 
smoking, and alcohol consumption), and occupational factors (occupation, working hours, shift work, days off, and job strain)
nAdjusted for age, BMI, eGFR, Hypertension, DM, TC/HDL-C, sleep duration, smoking, alcohol drinking, regular exercise, and snoring ≥3/week
bAdjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body 
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.
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specific age group are needed to further clarify this 
concern. Furthermore, ethnic-specific variations in 
sleep parameters and association with subclinical CVD 
have not been discussed and compared in these studies 
and thus question the need of further studies discuss-
ing the comparison of subclinical CVD burden in the 
multi-ethnic populations. Another concern is that 
most of the studies used in this review are cross sec-
tional and as a result, causality cannot be determined. 
Our findings show the need for follow up studies to 
assess the rapid progression of subclinical CVD with 
sleep disturbances. This will further clarify the associa-
tion of sleep parameters with an increased subclinical 
and clinical CVD burden. Finally, the implications of 
the associations demonstrated in our review are 
unclear. Should individuals with sleep disturbances be 
considered candidates for subclinical CVD screening? 
Most sleep disturbance treatment focuses on lifestyle 
modification, which is beneficial for CVD. However, 
in scenarios where one is found to have these findings, 
should one be a candidate for aggressive preventive 
pharmacotherapy such as Statins ? What will be the 
dardized duration, some studies used 6 hours as refer-
ence sleep duration, some used 7 hours, some used 8 
hours and some studies even used 6 –8 hours as refer-
ence sleep duration. The assessment of subjective and 
objective sleep quality was also different among the 
studies used in this review. Some studies used insom-
nia vs. non-insomnia, some used shift vs non-shift 
work, some used fragmentation index and/or arousal 
index and/or REM/Non-REM sleep to assess the sleep 
quality. A few studies that examined both subjective 
and objective sleep parameters demonstrated different 
outcomes depending on the nature of the predictor 
variable used in their analysis (subjective versus objec-
tive).
Some of the studies included in our review are of 
questionable methodological quality, which may be 
another source of observation bias. The population 
discussed in this systematic review ranges from 20 to 
87 years and due to heterogeneous nature of these 
studies we could not conclude what age groups were 
at more risk of subclinical CVD based on their sleep 
disturbances, thus more focused studies directed to 















PWV cm/sec.: [Sleep Deprivation (SD) vs 
Regular Sleep (RS)]: 
5.33±0.46 vs 5.15±0.26; p=0.001
Augmentation index (AIx) s: [SD vs RS ]:
20.5±11.9 vs 26.0±8.4%; p=0.008
Turkish population.





PWV cm/sec: [Good vs. Poor sleep quality] 
95% CI Adjb:
Men: 0.0 (Ref.) vs. 7.6 (1.2 to 13.9)
Women: 0.0 (Ref.) vs. 2.7 (－5.3 to 10.7)
Poor subjective sleep qual-
ity was associated with 
increase in PWV in men 
only in adjusted model.





PWV cm/s: [Among sleep quality groups] 
(95% CI) Adjo
Good: 1523 (1500, 1547)
Average: 1570 (1533, 1606)
Poor: 1604 (1547, 1661); p＜0.05
Poor sleep quality associ-
ated with higher PWV





PSQI sleep quality score and ABI (rho=
－0.31); p＜0.005
Lower the ABI, more the 
arterial stiffness.
Objective Sleep Quality
Not even a single study have described the association of objective sleep Quality with Arterial Stiffness.
bAdjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body 
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.
oAdjusted for age, gender, BMI, morningness eveningness questionnaire, Beck Depression inventory, energy intake, alcohol intake, current smok-
ing, physical activity, systolic BP, HbA1c, total cholesterol, HDL-cholesterol, triglyceride and sleep duration
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most cost effective method for screening ? Unfortu-
nately, no consensus exists in this specific area.
Conclusion
In conclusion, based on our systematic review, 
individuals with sleep disturbances, both quantitative 
and qualitative, have an accelerated subclinical CVD 
burden in the form of augmented Coronary Artery 
Calcium (CAC), increased Carotid Intima Media 
Thickness (CIMT), impaired endothelial function, 
and augmented arterial stiffness. Table 6 provides a 
snapshot of association of non-Invasive Subclinical 
CVD assessment tools with sleep duration and sleep 
quality. These findings suggest that association 
between sleep disturbances and increased CVD risk is 
exemplified by early changes in sub-clinical CVD sta-
tus. Important issues that need further exploration 
include the public awareness of regular sleep habits, 
and potential consequences of compromised sleep 
duration and quality in terms of causing hypertension, 
high cholesterol and risk of diabetes. There is a need 
to identify appropriate screening and treatment strate-
gies across different group of populations with sleep 
disturbances and whether these preventive approaches 
can slow progression of sub-clinical CVD and reduc-
tion in clinical events. Comprehensive studies aimed 
at answering these key questions can facilitate genera-
tion of information to guide preventive efforts in this 




Subjective sleep duration Vs Reference 
Sleep Duration (6-8 hrs)
Objective sleep duration Vs Reference 





























































Association variable: In this review some studies showed positive and some studies showed negative and some studies showed lack of an association 
between sleep duration and sleep quality with Non-Invasive Subclinical CVD assessment tools.
Association present: In this review most of the studies showed presence of an association between sleep duration and sleep quality with No-Invasive 
Subclinical CVD assessment tools.
Lack of association: In this review most of the studies showed lack of an association between sleep duration and sleep quality with Non-Invasive 
Subclinical CVD assessment tools.
Subjective Sleep Quality: Expressed as PSQI, good vs PSQI bad sleep quality, insomnia vs non-insomnia, shift vs. non-shift work, arousal index, 
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